San Francisco Biotechnology Network | Bay Area Life Science News, Jobs & Events
  • Home
  • About
  • News
    • SFBN Trending & Featured News & Jobs
  • SFBN Jobs
    • Submit a Job
  • Subscribe
  • Contact
News Ticker
  • [ February 3, 2023 ] Senior Scientist, Bioanalytical Sciences (PK/ADA) – Beyond a Resume – San Francisco, CA San Francisco Biotech Jobs
  • [ February 3, 2023 ] Researchers take a step toward novel quantum simulators News
  • [ February 2, 2023 ] SAP Serialization Business Analyst – Openmind Technologies – San Francisco, CA San Francisco Biotech Jobs
  • [ February 2, 2023 ] Research Associate – CyanVac, LLC – Los Gatos, CA San Francisco Biotech Jobs
  • [ February 2, 2023 ] Arcellx to Participate in Upcoming Investor Conferences News
HomeNewsSTAT+: Kite to buy Tmunity Therapeutics, Carl June’s troubled CAR-T startup

STAT+: Kite to buy Tmunity Therapeutics, Carl June’s troubled CAR-T startup

December 20, 2022 San Francisco Biotechnology Network News News Comments Off on STAT+: Kite to buy Tmunity Therapeutics, Carl June’s troubled CAR-T startup
Kite's two recent deals represent notable investments in a type of CAR-T that some had thought may become obsolete.

Click to view original post

  • Biotech
  • Biotechnology
  • cancer
  • STAT+
Previous

Ganymede Bio, the Cloud Provider Purpose-Built for the Life Sciences and Manufacturing Industries, Raises $12.75 Million in Series A Funding

Next

Quantum Leap Healthcare Collaborative Announces Positive Result of Oral Paclitaxel in Combination with a PD-1 and Carboplatin from I-SPY2 TRIAL in Neoadjuvant Breast Cancer

Related Articles

No Picture
News

Targeted cell control

October 5, 2022 San Francisco Biotechnology Network News News Comments Off on Targeted cell control

A new method for prompting cells to create specific proteins can more accurately focus on which cells make the proteins and when. Given the diverse purposes of proteins in the body, this could lead to advances in medical treatments and research, among … […]

No Picture
News

STAT+: Cognito Therapeutics raises $50 million for Alzheimer’s treatment tech

June 28, 2022 San Francisco Biotechnology Network News News Comments Off on STAT+: Cognito Therapeutics raises $50 million for Alzheimer’s treatment tech

Cognito Therapeutics is developing technologies to treat cognitive decline. It’s also collecting a trove of data on neurological diseases. […]

No Picture
News

STAT+: Pharma companies face shareholder proposals to widen access to medicines, rework business plans

March 30, 2022 San Francisco Biotechnology Network News News Comments Off on STAT+: Pharma companies face shareholder proposals to widen access to medicines, rework business plans

“These companies were founded on a mission of meeting human health needs… We want to make sure their policies and practices are aligned with that,” said Cathy Rowan, director of… […]

POST A JOB

Featured Jobs

Follow Us On Twitter

Tweets by @sdbn

Networking & Associations

  • AWIS-SF
  • Bay Area Society for Neuroscience
  • BioScience Forum
  • California Life Sciences Association
  • Meetup: Bay Area Life Tech
  • Meetup: East Bay Bio Network
  • Meetup: San Francisco Biotechnology Meetup
  • Meetup: San Francisco Life Science Professionals
  • Parenteral Drug Association West Coast Chapter
  • SynBioBeta
  • Women in Bio San Francisco

Copyright © 2022 Biotech Networks, LLC

Get Biotech Networks Briefs in Your Inbox: Trending News & Featured Jobs